Skip to content

Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures

Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01803789
Acronym
1-2-KiWI
Enrollment
292
Registered
2013-03-04
Start date
2013-05-31
Completion date
2017-07-31
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Metacarpal Bone

Keywords

Metacarpal V Fractures, Single Kirschner Wires, Double Kirschner Wires

Brief summary

Metacarpal V fractures are injuries of the upper extremities. They occur frequently, primarily in young adults.These fractures are caused by falling on the fist, sports accidents and direct or indirect forces. Surgical intervention is necessary for fractures with a strong palmar angulation of the metacarpal bone or rotational deformity of the small finger. Due to the absence of guideline recommendations decisions about therapy are made taking into account logistical aspects, available hardware, individual expertise and preferences. The objective of the study is to compare the advantages and disadvantages of single versus double Kirschner wires for intramedullary fixation of metacarpal V fractures in order to standardize national therapy procedures. Primary hypothesis: In the surgical therapy of the dislocated and/or rotational deformed metacarpal V neck fracture, osteosynthesis with a single Kirschner wire is not inferior to osteosynthesis with a double Kirschner wire with regard to the functional outcome after 6 month, as measured with the Disabilities of the Arm, Shoulder and Hands Score (DASH).

Interventions

DEVICESingle Kirschner Wire
DEVICEDouble Kirschner Wire

Sponsors

Deutsche Arthrose-Hilfe
CollaboratorOTHER
University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥18 years with a metacarpal V neck fracture with a palmar angulation and/or shortening and /or rotational deformity as determined on radiological diagnosis * Trauma within 10 days before appearing in the study centre * No specific medical treatment before * Ability to fully understand the character and implications of the clinical trial * Written or oral (in case of an injury of the dominant hand, if so attested by witnesses)consent

Exclusion criteria

* Indications for conservative therapy * Patient is not suitable for anaesthesia * Other physical conditions or characteristics which made surgical interventions inappropriate or to risky (e.g. open fractures, polytrauma, pregnancy, acute infections, pathological fractures) * Prior participation in this study (e.g. injury of the contralateral hand) or participation in other interventional studies with the same objective * Physical or mental diseases which makes the consequent participation in diagnostic, therapy and the follow-up-examinations unlikely * Lacking language skills

Design outcomes

Primary

MeasureTime frame
Differences in functional outcome of the therapy with single or double Kirschner wires measured with the DASH score6 months after randomisation

Secondary

MeasureTime frame
Shortening of the metacarpus >2mm6 months after randomisation
Palmar angulation >30°6 months after randomisation
Non-union/Pseudarthrosis6 months after randomisation
Limitation of fist closure6 months after randomisation
Flexion or extension lag6 months after randomisation
Malposition or angulation in the frontal and sagittal planes of max. 5°6 months after randomisation
Duration of surgical intervention6 months after randomisation
Rate of re-interventions6 months after randomisation
Rate of infections6 months after randomisation
Rate of perforation/dislocation/break of the fracture fixation devices6 months after randomisation
Duration of inability to work6 months after randomisation
Pain intensity <10 points (VAS)6 months after randomisation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026